Locked Out of a Cure? Only a Fraction of Early Alzheimer’s Patients Eligible for New Drugs Post author:Randy Banks Post published:October 8, 2023 Post category:News Only a small fraction of older adults with early Alzheimer’s symptoms are eligible for new monoclonal antibody treatments, according to a recent study. Full Story You Might Also Like FDA Grants Accelerated Approval for Alzheimer’s Disease Treatment March 13, 2023 How to deal with dementia-related wandering September 4, 2023 Understanding Wandering Risks With Older Adults June 4, 2024
Only a small fraction of older adults with early Alzheimer’s symptoms are eligible for new monoclonal antibody treatments, according to a recent study. Full Story